Mesoblast Limited
Mesoblast Limited
MESO
Valuace
100
Růst
83
Zdraví
71
Cena
$ 15.11
Dnes
--0.28 (-1.58%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
1.9B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-17%
ROA
-13%
PE
-21
PS
125
Cena 1R
10-22
⌀ Cena
14.62
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Biofarmaceutická společnost Mesoblast Limited vyvíjí a komercializuje alogenní buněčné léky ve Spojených státech, Austrálii, Singapuru, Velké Británii a Švýcarsku. Společnost nabízí produkty v oblasti kardiovaskulárních, páteřních ortopedických poruch, onkologie, hematologie a nemocí zprostředkovaných imunitním systémem a zánětlivých onemocnění. Její proprietární technologická platforma regenerativní medicíny je založena na specializovaných buňkách známých jako mezenchymální lineární buňky. Mezi produkty společnosti zařazené do klinických studií fáze III patří remestemcel-L pro léčbu akutního štěpu refrakterního na steroidy proti hostiteli, stejně jako syndrom akutní respirační tísně způsobený infekcí COVID-19; Rexlemestrocel-L pro léčbu pokročilého chronického srdečního selhání; a MPC-06-ID pro chronickou bolest dolní části zad způsobenou degenerativním onemocněním plotének. Vyvíjí se také MPC- 300-IV pro léčbu biologické refrakterní revmatoidní artritidy diabetické nefropatie. Společnost má strategické partnerství se společností Tasly Pharmaceutical Group, která nabízí MPC-150-IM pro srdeční selhání a MPC-25-IC pro srdeční infarkty v Číně; JCR Pharmaceuticals Co. Ltd. pro léčbu hojení ran u pacientů s epidermolýzou bullosa; a Grünenthal pro vývoj a komercializaci buněčné terapie pro léčbu chronické bolesti v dolní části zad. Společnost Mesoblast Limited byla založena v roce 2004 a má sídlo v australském Melbourne.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
73
Založení
2010-01-20
Adresa
55 Collins Street
CEO
Silviu Itescu FACP, FACRA, FRACP, MBBS

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues17.217.25.97.510.27.532.216.717.32.442.523.726.028.838.3120.90.0
Cost of Revenues53.15.141.154.90.00.00.00.05.50.00.00.00.00.00.00.00.0
Gross Profit-35.912.1-35.2-47.410.27.532.216.711.82.442.523.726.028.838.3120.90.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues7.07.01.61.61.31.31.71.72.11.9
Cost of Revenues23.223.23.33.310.810.89.79.715.413.3
Gross Profit-16.2-16.2-1.7-1.7-9.6-9.6-8.0-8.0-13.3-11.4
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.027.232.853.056.259.865.958.950.077.655.343.136.915.37.6
Selling General & Admin Expenses0.00.00.053.158.063.650.937.027.435.152.365.454.251.728.111.83.6
Depreciation & Amortization4.36.41.94.14.44.33.72.12.73.12.22.01.10.80.40.20.2
Total Operating Expenses74.174.549.076.890.8115.1107.697.992.092.598.4137.198.488.965.027.211.1
Operating Income-110.0-62.4-84.1-69.3-81.0-111.9-79.1-83.3-75.2-90.0-55.9-113.4-72.4-60.1-48.793.8-10.4
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.06.77.1
Selling General & Admin Expenses0.00.00.00.00.00.00.00.014.412.7
Depreciation & Amortization1.61.60.50.50.40.40.50.50.91.0
Total Operating Expenses18.118.118.918.912.412.412.112.120.916.4
Operating Income-34.4-34.4-20.6-20.6-22.0-22.0-20.1-20.1-19.1-14.5
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income-7.53.61.80.80.00.00.50.70.40.00.00.00.00.00.00.00.7
Interest Expense10.722.920.719.416.910.713.311.31.80.09.310.54.30.00.00.00.0
Other Expense8.2-39.4-4.0-12.8-10.612.2-8.3-15.510.5-0.1-25.64.6-4.20.0-22.0-1.5-4.4
IBT-101.8-101.8-88.1-82.1-91.6-99.6-87.4-98.8-66.0-90.2-90.8-119.4-81.0-60.1-48.792.2-14.8
Income Tax Expense0.30.3-0.2-0.2-0.2-0.8-9.4-9.0-30.7-13.4-86.76.10.01.622.41.6-0.7
Net Income-102.1-102.1-88.0-81.9-91.3-98.8-77.9-89.8-35.3-76.8-4.1-119.4-81.0-61.7-71.190.6-14.8
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income-3.8-3.80.00.00.00.00.00.04.34.9
Interest Expense0.00.05.35.34.34.35.15.13.85.0
Other Expense7.37.3-3.2-3.2-5.7-5.73.73.7-3.2-4.2
IBT-27.0-27.0-23.9-23.9-27.8-27.8-16.3-16.3-22.0-18.6
Income Tax Expense0.10.10.10.10.00.0-0.1-0.10.00.0
Net Income-27.1-27.1-24.0-24.0-27.7-27.7-16.3-16.3-21.9-18.6
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-0.11$-0.70$-0.83$-0.70$-0.90$-0.38$-0.96$-0.06$-1.84$-0.25$-0.20$-1.24$2.07$-0.52
EPS Diluted$0.00$0.00$0.00$-0.11$-0.70$-0.83$-0.70$-0.90$-0.38$-0.96$-0.06$-1.84$-0.25$-0.20$-1.24$1.97$-0.52
Shares Outstanding127.3120.898.7739.0129.8119.1112.199.993.179.872.864.8319.3310.457.143.828.4
Diluted Shares Outstanding127.3120.898.7739.0129.8119.1112.199.993.179.972.864.8319.4310.557.146.028.4
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.03$-0.03
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.03$-0.03
Shares Outstanding127.3127.3114.1114.1112.2112.285.185.1786.6735.2
Diluted Shares Outstanding127.3127.3114.2114.2112.2112.285.185.1787.2736.6
Current Assets TTM 2025202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents62.6161.262.670.960.0136.9129.350.437.845.821.927.53.87.9206.7263.232.0
Short Term Investments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments62.6161.262.670.960.0136.9129.350.437.845.821.927.53.87.9206.7263.232.0
Accounts Receivable21.014.921.07.04.44.81.64.150.43.74.15.26.112.110.72.11.4
Inventory0.022.20.00.40.0-4.8-1.6-4.1-0.313.959.1116.6192.6308.40.00.00.0
Other Current Assets0.06.12.92.95.411.37.212.113.20.33.810.11.33.50.30.20.1
Total Current Assets86.5204.486.581.769.8148.2136.562.5101.163.688.8159.5203.7331.8217.7265.533.5
Current Assets 4-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents161.238.038.062.663.077.177.670.948.467.2
Short Term Investments0.00.00.00.00.00.00.00.00.20.0
Total Cash & ST Investments161.238.038.062.663.077.177.670.948.667.2
Accounts Receivable14.91.71.721.01.64.01.87.08.45.1
Inventory22.224.224.20.00.00.00.00.44.65.8
Other Current Assets6.15.85.82.921.94.05.82.94.25.4
Total Current Assets204.469.769.786.586.585.285.281.761.478.1
Long-Term Assets TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment3.85.83.86.510.012.110.30.81.11.83.15.74.72.82.00.60.2
Goodwill134.5134.5134.5134.5134.5134.5134.5134.5134.5134.5134.5175.1140.5127.7116.2109.70.0
Intangible Assets441.3437.4441.3442.7444.2446.1447.1448.7450.2451.9453.4671.6547.4420.1381.0365.60.4
Long-Term Investments1.01.41.01.81.82.11.92.32.32.02.03.00.00.00.00.05.3
Other Long-Term Assets0.51.32.10.51.91.73.33.33.41.92.33.13.01.30.00.00.0
Total Long-Term Assets582.7580.3582.7587.8592.3596.5597.1589.6591.4592.1595.2858.5695.6551.9502.7497.86.0
Total Assets669.2784.7669.2669.4662.1744.7733.6652.1692.4655.7684.01,017.9899.3883.7720.5763.339.5
Long-Term Assets 4-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment5.86.26.23.83.85.55.56.57.18.2
Goodwill134.5134.5134.5134.5134.5134.5134.5134.5134.5134.5
Intangible Assets437.4440.4440.4441.3441.3442.1442.1442.7443.1443.4
Long-Term Investments1.41.21.21.01.00.80.81.82.01.9
Other Long-Term Assets1.31.31.32.12.12.22.20.52.41.9
Total Long-Term Assets580.3583.6583.6582.7582.7585.1585.1587.8589.1589.9
Total Assets784.7653.3653.3669.2669.2670.3670.3669.4650.4668.1
Current Liabilities TTM 2025202420232022202120202019201820172016201520142013201220112010
Accounts Payable7.119.17.120.123.119.625.013.118.921.827.236.820.720.811.63.01.1
Short-Term Debt16.556.816.510.08.256.036.014.00.00.00.00.05.70.03.30.00.0
Other Current Liabilities4.626.749.75.420.118.729.217.35.114.92.36.70.313.61.40.60.5
Current Liabilities73.2102.673.242.051.494.390.144.324.036.729.463.042.750.644.530.81.6
Current Liabilities 4-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable19.111.911.97.17.110.80.020.121.023.0
Short-Term Debt56.819.919.916.516.511.48.510.010.99.8
Other Current Liabilities26.741.041.049.749.71.012.15.422.021.8
Current Liabilities102.672.872.873.273.231.431.442.053.954.6
Long-Term Liabilities TTM 2025202420232022202120202019201820172016201520142013201220112010
Long-Term Debt102.471.3102.4106.598.749.563.367.359.40.00.00.00.00.00.00.00.0
Capital Leases4.66.34.67.710.311.39.80.00.00.00.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.00.711.120.149.362.7194.5158.6146.0132.9127.80.0
Total Liabilities188.8187.2188.8167.6165.1163.3184.3171.1146.4138.9155.9408.6327.6253.4241.6247.41.6
Long-Term Liabilities 4-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt71.3106.2106.2102.4102.4110.6110.6106.5103.7102.0
Capital Leases6.37.17.14.64.66.26.27.78.38.9
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities187.2192.1192.1188.8188.8161.6161.6167.6168.3168.1
Total Common Equity TTM 2025202420232022202120202019201820172016201520142013201220112010
Common Stock1,310.81,508.81,310.81,249.11,165.31,163.21,051.5910.4889.5830.4770.3737.3677.1654.50.00.00.0
Retained Earnings-908.8-1,010.9-908.8-820.8-738.9-647.6-548.8-470.0-380.2-344.9-268.1-298.2-178.8-97.8-36.235.0-55.6
Comprehensive Income78.399.578.373.570.765.846.640.636.731.226.0170.373.473.630.03.75.6
Total Common Equity480.4597.4480.4501.8497.0581.4549.3481.1546.0516.8528.2609.4571.7630.3478.8515.837.9
Total Common Equity 4-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock1,508.81,320.21,320.21,310.81,310.81,286.21,286.21,249.11,207.51,207.7
Retained Earnings-1,010.9-956.7-956.7-908.8-908.8-853.3-853.3-820.8-798.9-780.3
Comprehensive Income99.597.897.878.378.375.875.873.573.672.6
Total Common Equity597.4461.3461.3480.4480.4508.7508.7501.8482.2500.0
Other TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Debt118.9128.2118.9116.5106.9105.599.381.359.40.00.00.00.00.00.00.00.0
Book Value480.4597.4480.4501.8497.0581.4549.3481.1546.0516.8528.2609.4571.7630.3478.8515.837.9
Other 4-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value597.4461.3461.3480.4480.4508.7508.7501.8482.2500.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-32.5-102.1-88.0-81.9-91.3-98.8-77.9-89.8-35.3-76.8-4.1-119.4-81.0-61.7-71.190.6-14.8
Depreciation & Amortization2.46.44.74.14.44.33.72.12.73.12.22.01.10.80.40.20.2
Stock-Based Compensation2.222.15.93.75.512.57.54.46.25.33.48.69.412.312.13.31.0
Change Working Capital3.8-3.0-2.6-2.54.9-8.413.320.4-8.9-13.8-0.15.3-0.9-7.2-0.3117.00.3
Change In Accounts Receivable2.16.3-15.5-0.10.1-1.70.95.0-6.1-0.9-0.50.32.62.10.00.00.0
Change In Accounts Payable0.00.00.00.00.00.00.00.00.00.00.00.00.010.00.00.00.0
Change In Inventories0.00.80.00.00.00.00.00.00.00.00.00.00.0-1.10.00.00.0
Other Non-cash Items-2.426.431.813.511.0-15.46.514.0-9.00.2-2.6-5.0-12.1-3.312.13.31.0
Cash from Operations-27.50.00.0-63.3-65.8-106.7-56.4-57.8-75.0-95.5-88.0-121.7-81.9-54.1-72.1108.2-9.7
Cash Flow From Operating Activities 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Net Income0.00.0-27.10.0-24.00.00.00.0-16.3-16.3
Depreciation & Amortization0.00.02.20.01.00.00.00.01.21.2
Stock-Based Compensation0.00.03.50.07.60.00.00.01.11.1
Change Working Capital0.00.0-5.30.0-2.80.00.00.01.91.9
Change In Accounts Receivable0.00.0-6.30.08.80.00.00.01.01.0
Change In Accounts Payable0.00.00.00.00.00.00.00.00.00.0
Change In Inventories0.00.00.40.00.00.00.00.00.00.0
Other Non-cash Items-15.6-14.910.2-12.77.9-10.30.00.0-1.2-1.2
Cash from Operations0.00.00.00.00.00.00.00.00.00.0
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.3-0.7-0.3-0.3-0.2-1.6-2.2-0.3-0.2-0.3-0.9-2.7-37.9-2.8-2.7-0.5-0.1
Acquisitions0.00.00.00.00.00.0-1.0-0.7-1.00.00.0-2.30.00.00.03.40.0
Investments0.00.00.00.00.00.00.00.00.00.0-0.8-0.9-1.5-2.2-1.30.00.0
Sales of Investment0.20.20.20.10.00.00.00.00.00.00.0-0.20.00.00.00.00.0
Other Investing Activities0.20.00.00.10.00.00.00.00.00.50.00.6-1.40.09.31.7-0.3
Cash from Investing-0.10.00.0-0.2-0.2-1.6-3.3-1.0-1.20.1-1.7-5.6-40.8-5.05.34.7-0.3
Cash Flow From Investing Activities 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Capital Expenditure-0.1-0.3-0.5-0.1-0.10.00.00.00.0-0.2
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.20.00.00.00.20.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Investing0.00.00.00.00.00.00.00.00.00.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-13.50.00.0-2.7-58.2-2.9-2.10.0-0.40.00.00.00.00.00.00.00.0
Debt Issued259.99.22.412.259.79.120.221.959.80.00.00.00.00.00.00.00.0
Issuance of Common Stock65.40.00.088.60.2106.3144.930.340.661.968.560.02.5174.94.9126.926.8
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-7.30.00.0-11.548.211.1-5.841.428.4-1.9-6.5-0.60.0-5.50.0-0.8-1.3
Cash from Financing40.30.00.074.5-9.9114.5137.071.668.660.062.159.42.4169.34.9126.125.5
Cash Flow From Financing Activities 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued0.0128.2128.2126.1126.17.2118.9-3.12.92.7
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.00.00.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-8.498.6-8.410.9-76.47.678.912.7-8.0-35.2-29.8-52.3-118.9109.7-56.5231.215.5
Closing Cash Balance63.0161.663.071.360.4136.9129.350.437.845.880.9144.1196.4315.3206.7263.232.0
Cash position 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Net Change in Cash-14.7-16.8-20.5144.0-13.1-11.8-13.4-1.224.4-18.1
Closing Cash Balance130.0144.7161.6182.138.051.163.076.477.653.2
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-27.9-50.7-48.8-63.6-66.0-108.3-58.6-58.1-75.2-95.8-88.9-124.4-119.8-56.9-74.8107.8-9.7
Real Free Cash Flow-30.1-72.8-54.7-67.2-71.6-120.8-66.1-62.4-81.4-101.1-92.3-133.0-129.2-69.2-86.9104.5-10.8
Free Cash Flow 2-20261-20264-20253-20252-20251-20254-20243-20242-20241-2024
Free Cash Flow-15.7-15.3-14.9-12.8-10.4-10.4-0.10.0-13.3-14.4
Real Free Cash Flow-15.7-15.3-18.4-12.8-18.0-10.4-0.10.0-14.4-15.5
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-21.1-72-1.4
P/S125379.79.4
P/B3.65.85.2
P/FCF-36-66.4-1.5
Market cap$1.9$2.4
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets16.3 %9.2 %0 %
Debt to Income-125.5 %-77.2 %0 %
Debt to Free cash flow-206.2 %-49.4 %0 %
Interest expense percentage-9.7 %-12.7 %44.7 %
Current ratio2 1.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-17.1 %-13 %0 %
ROA-13 %-9.6 %0 %
CapEx to Revenue3.9 %5.2 %0 %
RaD to Revenue0 %424.9 %0 %
ROEM212,321.0 175615.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin-208.5 %14.7 %68.7 %
Operating margin-639.5 %-787.2 %35.5 %
Net margin-593.9 %-761.1 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding127.3 mil 160.8 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader